Japan Needle Free Injections Market Outlook to 2023

2017-08-01
Price :
Published : Aug-2017
No. of Pages : 30
Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Needle Free Injections Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Needle Free Injections Market, Japan 7
3.1 Needle Free Injections Market, Japan, Revenue ($m), 2009-2016 7
3.2 Needle Free Injections Market, Japan, Revenue ($m), 2016-2023 8
3.3 Needle Free Injections Market, Japan, Volume (Units), 2009-2016 9
3.4 Needle Free Injections Market, Japan, Volume (Units), 2016-2023 10
3.5 Needle Free Injections Market, Japan, Average Price ($), 2009-2023 11
3.6 Needle Free Injections Market, Japan, Distribution Share by Revenue ($m), 2015-2016 12
3.7 Needle Free Injections Market, Japan, Company Share by Revenue ($m), 2016 13
4 Overview of Key Companies in Japan, Needle Free Injections Market 15
4.1 Bioject Medical Technologies Inc 15
4.1.1 Company Overview 15
4.2 INJEX - Equidyne Systems 15
4.2.1 Company Overview 15
4.3 Antares Pharma Inc 15
4.3.1 Company Overview 15
4.4 MK Global Co. 15
4.4.1 Company Overview 15
4.5 The European Pharma Group 15
4.5.1 Company Overview 15
5 Needle Free Injections Market Pipeline Products 16
6 Financial Deals Landscape 17
6.1 Debt Offerings 17
6.1.1 Daiichi Sankyo to Raise USD713.4 Million in Public Offering of 0.81% 5th Series Bonds Due 2036 17
6.1.2 Daiichi Sankyo to Raise USD237.8 Million in Public Offering of 1.2% 6th Series Bonds Due 2046 18
7 Recent Developments 19
7.1 Corporate Communications 19
7.1.1 Feb 24, 2017: Daiichi Sankyo Appoints New Group Corporate Officers 19
7.1.2 Feb 09, 2017: Terumo Announces Change of Executive Officers 19
7.1.3 Jan 31, 2017: Daiichi Sankyo Announces New Chairman and President 20
7.1.4 Sep 06, 2016: Daiichi Sankyo Announces New Global Head of Development 20
7.2 Government and Public Interest 21
7.2.1 Jul 03, 2017: 15th Takamine Memorial Daiichi Sankyo Prize Winner Announced 21
7.3 Other Significant Developments 21
7.3.1 Apr 27, 2017: Daiichi Sankyo Announces 15 Billion Yen Manufacturing Investment to Support Acceleration of Antibody Drug Conjugate Portfolio 21
7.3.2 Jan 10, 2017: Daiichi Sankyo Announces Reorganization of Research & Development System 22
7.3.3 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 22
7.4 Strategy And Business Planning 23
7.4.1 Feb 24, 2017: Daiichi Sankyo Announces Organizational Restructuring Effective as of April 1, 2017 23
7.4.2 Feb 15, 2017: Daiichi Sankyo Strengthens Authorized Generic Business through Daiichi Sankyo Espha 23
7.4.3 Feb 10, 2017: Daiichi Sankyo Announces Further Reorganization of its Research & Development Structure 24
7.4.4 Jan 31, 2017: Terumo Opens a Branch in Yangon 24
8 Appendix 26
8.1 Research Methodology 27
8.1.1 Coverage 27
8.1.2 Secondary Research 27
8.1.3 Primary Research 28
8.1.4 Company Share Analysis 28
8.1.5 Distribution Share Analysis 28
8.1.6 Benchmarking 29
8.2 GlobalData Consulting 29
8.3 Contact Us 30
8.4 Disclaimer 30

1.1 List of Tables
Table 1: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 7
Table 2: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 8
Table 3: Needle Free Injections Market, Japan, Volume (Units), Historic, 2009-2016 9
Table 4: Needle Free Injections Market, Japan, Volume (Units), Forecast, 2016-2023 10
Table 5: Needle Free Injections Market, Japan, Average Price ($), Historic, 2009-2016 11
Table 6: Needle Free Injections Market, Japan, Average Price ($), Forecast, 2016-2023 11
Table 7: Needle Free Injections Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016 12
Table 8: Needle Free Injections Market, Japan, Company Share by Revenue ($m), USD Constant, 2016 14
Table 9: Needle Free Injections Market Pipeline Products 16
Table 10: Daiichi Sankyo to Raise USD713.4 Million in Public Offering of 0.81% 5th Series Bonds Due 2036 17
Table 11: Daiichi Sankyo to Raise USD237.8 Million in Public Offering of 1.2% 6th Series Bonds Due 2046 18

1.2 List of Figures
Figure 1: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 7
Figure 2: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 8
Figure 3: Needle Free Injections Market, Japan, Volume (Units), Historic, 2009-2016 9
Figure 4: Needle Free Injections Market, Japan, Volume (Units), Forecast, 2016-2023 10
Figure 5: Needle Free Injections Market, Japan, Company Share (%) 2016 13
Filed in: Medical Device, Orthopedic Devices
Publisher : GlobalData